Lianjun Zhang

6PUBLICATIONS
44CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 08, 2026
The HDAC8-U2AF1 Axis Dysregulates DNA Damage-Responsive RNA Splicing and Creates Targetable Vulnerabilities in Acute Myeloid Leukemia.

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|May 12, 2026
Targeting PRMT9 overcomes venetoclax resistance in AML by modulating splicing and inhibiting translation.

|Apr 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growth.

Melissa Valerio, Wenyuan Wei, Hyunjun Kang

|Dec 15, 2025
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia.

Lianjun Zhang, HyunJun Kang, Melissa Valerio

Pageof 1

Frequent Collaborators

5 joint publications

Ya-Huei Kuo

3 joint publications

Le Xuan Truong Nguyen

3 joint publications

Guido Marcucci

3 joint publications

Yu-Hsuan Fu